NIH stops funding research using human fetal tissue from elective abortions

The NIH will stop funding research using human fetal tissue from elective abortions. This policy change impacts biomedical research and aligns with previous administration actions. The ban, effective immediately, aims to modernize research by investing in alternative technologies. While internal research was previously restricted, this expands the ban to all NIH-funded projects. Fetal tissue has been crucial for research into diseases like diabetes and Alzheimer's, and for vaccine development. The NIH stated that projects using this tissue have been declining.